Search research articles
Contact Us
Filters
Showing results (121-130 of 372) with videos related to
Page
of 38
Sort By:
Expert Review of Anti-Infective Therapy
|
October 7, 2009
Pegylated IFN-alpha2a and ribavirin in the treatment of hepatitis C
Alessio Aghemo, Maria Grazia Rumi, Massimo Colombo
Gastroenterology
|
June 23, 2020
Asbestos Exposure and Increased Risk of Intrahepatic Cholangiocarcinoma: Enough to Infer Causality?
Carlo La Vecchia, Marcello Lotti, Massimo Colombo
Clinics and Research in Hepatology and Gastroenterology
|
March 26, 2011
Does interferon therapy prevent hepatocellular carcinoma in patients with chronic viral hepatitis?
Elena Vezali, Alessio Aghemo, Pietro Lampertico, et al.
Current Opinion in Virology
|
April 19, 2017
Direct-acting antivirals: the endgame for hepatitis C?
Roberta D'Ambrosio, Elisabetta Degasperi, Massimo Colombo, et al.
Hepatology (Baltimore, Md.)
|
December 1, 2005
Spectrum of NAFLD and diagnostic implications of the proposed new normal range for serum ALT in obese women
Daniele Prati, Agostino Colli, Dario Conte, et al.
Hepatology (Baltimore, Md.)
|
March 7, 2022
Low-dose aspirin reduces the risk of HBV-associated HCC even when administered short-term: Too good to be true?
Luca G Guidotti, Carlo La Vecchia, Massimo Colombo
Viruses
|
October 14, 2011
HBV and HCV therapy
Pietro Lampertico, Alessio Aghemo, Mauro Viganò, et al.
Environmental Monitoring and Assessment
|
August 29, 2020
Global approaches to assessing, monitoring, mapping, and remedying soil pollution
Natalia Rodríguez Eugenio, Ravi Naidu, Claudio Massimo Colombo
Journal of Hepatology
|
February 29, 2008
Management of liver diseases 2008. Foreword
Mario U Mondelli, Roberto de Franchis, Massimo Colombo
International Journal of Molecular Sciences
|
September 28, 2023
Hepatocellular Carcinoma Prevention in the Era of Hepatitis C Elimination
Jeffrey V Lazarus, Camila A Picchio, Massimo Colombo
Page
of 38
Search research articles
Search
Showing results (121-130 of 372) with videos related to
Sort By:
Page
of 38
Expert Review of Anti-Infective Therapy
|
October 7, 2009
Pegylated IFN-alpha2a and ribavirin in the treatment of hepatitis C
Alessio Aghemo, Maria Grazia Rumi, Massimo Colombo
Gastroenterology
|
June 23, 2020
Asbestos Exposure and Increased Risk of Intrahepatic Cholangiocarcinoma: Enough to Infer Causality?
Carlo La Vecchia, Marcello Lotti, Massimo Colombo
Clinics and Research in Hepatology and Gastroenterology
|
March 26, 2011
Does interferon therapy prevent hepatocellular carcinoma in patients with chronic viral hepatitis?
Elena Vezali, Alessio Aghemo, Pietro Lampertico, et al.
Current Opinion in Virology
|
April 19, 2017
Direct-acting antivirals: the endgame for hepatitis C?
Roberta D'Ambrosio, Elisabetta Degasperi, Massimo Colombo, et al.
Hepatology (Baltimore, Md.)
|
December 1, 2005
Spectrum of NAFLD and diagnostic implications of the proposed new normal range for serum ALT in obese women
Daniele Prati, Agostino Colli, Dario Conte, et al.
Hepatology (Baltimore, Md.)
|
March 7, 2022
Low-dose aspirin reduces the risk of HBV-associated HCC even when administered short-term: Too good to be true?
Luca G Guidotti, Carlo La Vecchia, Massimo Colombo
Viruses
|
October 14, 2011
HBV and HCV therapy
Pietro Lampertico, Alessio Aghemo, Mauro Viganò, et al.
Environmental Monitoring and Assessment
|
August 29, 2020
Global approaches to assessing, monitoring, mapping, and remedying soil pollution
Natalia Rodríguez Eugenio, Ravi Naidu, Claudio Massimo Colombo
Journal of Hepatology
|
February 29, 2008
Management of liver diseases 2008. Foreword
Mario U Mondelli, Roberto de Franchis, Massimo Colombo
International Journal of Molecular Sciences
|
September 28, 2023
Hepatocellular Carcinoma Prevention in the Era of Hepatitis C Elimination
Jeffrey V Lazarus, Camila A Picchio, Massimo Colombo
Page
of 38